Thrombocytopenia and Intravenous Heroin Use

  1. WILLIAM H. ADAMS, M.D.;
  2. ROBERT A. RUFO, M.D.;
  3. LILIA TALARICO, M.D.;
  4. STUART L. SILVERMAN, M.D.; and
  5. MARK J. BRAUER, M.D.
  1. Boston, Massachusetts

    Abstract

    Five young male heroin users presented with a syndrome resembling acute immune thrombocytopenic purpura. Although a viral, autoimmune, or toxic origin cannot be conclusively excluded at present, data are most consistent with the hypothesis that the thrombocytopenia was due to a drug-related immunologic mechanism that resulted in peripheral platelet destruction. Epidemiologic considerations suggest the common agent involved in their illnesses was present in the heroin they used. Although glucocorticoid therapy was followed by clinical recovery in four of the five patients (one was lost to follow-up), it is not certain that this represented a causal relation.

    Article and Author Information

    • ▸From the Thorndike Memorial Laboratory and the Department of Medicine, Boston City Hospital, Boston University School of Medicine; Boston, Massachusetts.

    • ▸Reprint requests should be addressed to William H. Adams, M.D.; Department of Medicine, Boston City Hospital; 818 Harrison Ave.; Boston, MA 02118.

      • Received December 22, 1977.
      • Accepted April 14, 1978.
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med August 1, 1978 vol. 89 no. 2 207-211
    1. » Abstract
    2. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. December 1, 2009, 151 (11)
    1. Alert me to current issues